Lamisil

Terbinafine, the active ingredient in Lamisil, is an allylamine antifungal presented as a topical formulation for topical use. It treats common fungal skin infections such as tinea corporis, tinea cruris, tinea pedis and tinea barbae in both adults and children.

GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamisil is an allylamine antifungal indicated for superficial dermatophyte infections. It works on the skin to eradicate the causative fungi.

- Tinea corporis: clears ring‑shaped body rash caused by dermatophytes. - Tinea cruris: treats groin area fungal infection, reducing redness and itching. - Tinea pedis: resolves athlete’s foot symptoms, eliminating scaling and odor. - Tinea barbae: eliminates beard‑area fungal infection, promoting normal skin appearance.

Topical terbinafine may cause local reactions, most of which are mild and reversible.

Common Side Effects: - Itching: mild to moderate sensation at the application site. - Burning: transient heat sensation during or after application. - Redness: localized erythema around the treated area. - Scaling: flaking of skin as the infection resolves. - Dryness: temporary loss of moisture at the site. - Irritation: mild discomfort or stinging.

Serious or Rare Side Effects: - Contact dermatitis: severe allergic skin reaction requiring medical attention. - Angioedema: swelling of face, lips or tongue. - Stevens‑Johnson syndrome: rare severe skin disorder. - Systemic absorption leading to liver enzyme elevation (very rare with topical use).

Before using Lamisil, consider the following safety measures.

- Avoid use on broken skin: do not apply to open wounds or ulcerated areas. - Do not apply to eyes or mucous membranes: avoid contact with eyes, mouth or genital mucosa. - Check for allergy to terbinafine: discontinue if hypersensitivity develops. - Limit use to recommended duration: follow the prescriber's or label's treatment period. - Store at room temperature below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Terbinafine topical may interact with other skin products or systemic medications.

Major Interactions (Avoid): - Concurrent systemic terbinafine: increases total terbinafine exposure. - Use with other topical irritants (e.g., salicylic acid): may exacerbate skin irritation.

Moderate Interactions (Monitor Closely): - Co‑application with corticosteroid creams: may alter absorption and efficacy. - Use with other antifungal agents: potential additive irritation. - Concomitant warfarin therapy: theoretical risk of altered coagulation if systemic absorption occurs.